General Healthy(605186)

Search documents
每周股票复盘:健麾信息(605186)转让1500万份私募基金份额
Sou Hu Cai Jing· 2025-07-26 22:32
上海健麾信息技术股份有限公司将其持有并尚未完成实缴的1500.00万份上海弘盛厚德私募投资基金合 伙企业(有限合伙)基金份额转让给黄志鸿,转让价格为人民币0元。转让完成后,公司仍持有弘盛厚 德基金份额1500万份。弘盛厚德基金规模为5.7071亿元,存续期限7年,投资目标为从事医疗健康行业 的创业投资活动。公司为一般有限合伙人,认缴出资3000.00万元,实缴1500.00万元,认缴出资比例 5.2566%。根据公司章程及相关规定,本次交易在公司董事长审批范围内,无需提交董事会、股东大会 审议,不构成关联交易和重大资产重组。黄志鸿与公司不存在关联关系或利益安排。转让协议约定,标 的份额转让价款为人民币0元,受让人承诺按时足额完成实缴出资,并配合完成相关变更登记手续。本 次交易有利于公司优化投资结构与布局,符合公司整体战略规划,不会对公司的财务状况和生产经营活 动产生重大影响。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 【公司公告汇总】健麾信息将其持有的1500.00万份私募基金份额转让给黄志鸿,转让价格为人民 币0元 公司公告 ...
上海健麾信息技术股份有限公司关于部分转让私募投资基金份额的公告
Shang Hai Zheng Quan Bao· 2025-07-24 20:53
证券代码:605186 证券简称:健麾信息 公告编号:2025-023 上海健麾信息技术股份有限公司 关于部分转让私募投资基金份额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 上海健麾信息技术股份有限公司(以下简称"公司")将其持有并尚未完成实缴的1,500.00万份上海弘 盛厚德私募投资基金合伙企业(有限合伙)(以下简称"弘盛厚德")基金份额转让给黄志鸿,转让价格 为人民币 0元。上述财产份额转让完成后,公司持有弘盛厚德基金份额1,500万份。 一、交易概述 公司于2023年参与投资设立私募投资基金弘盛厚德,该基金规模为人民币5.7071亿元,存续期限 7 年, 投资目标为从事医疗健康行业的创业投资活动。其中,公司为一般有限合伙人,认缴出资人民币 3,000.00万元,公司实缴1,500.00万元),认缴出资比例5.2566%。 为优化公司投资结构与布局,经友好协商,近日,公司与黄志鸿签署《基金份额转让协议》(以下简 称"转让协议")。根据转让协议约定,公司将尚未实缴的1,500.00万元认缴出 ...
健麾信息(605186) - 上海健麾信息技术股份有限公司关于部分转让私募投资基金份额的公告
2025-07-24 07:45
证券代码:605186 证券简称:健麾信息 公告编号:2025-023 根据《上海健麾信息技术股份有限公司章程》、《上海证券交易所股票上市 规则》等相关规定,本次交易在公司董事长的审批范围内,无需提交董事会、股 东大会审议。本次交易事项不构成关联交易,也不构成《上市公司重大资产重组 1 上海健麾信息技术股份有限公司 关于部分转让私募投资基金份额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示: 上海健麾信息技术股份有限公司(以下简称"公司")将其持有并尚未完成实 缴的 1,500.00 万份上海弘盛厚德私募投资基金合伙企业(有限合伙)(以下简称 "弘盛厚德")基金份额转让给黄志鸿,转让价格为人民币 0 元。上述财产份额 转让完成后,公司持有弘盛厚德基金份额 1,500 万份。 一、交易概述 公司于 2023 年参与投资设立私募投资基金弘盛厚德,该基金规模为人民币 5.7071 亿元,存续期限 7 年,投资目标为从事医疗健康行业的创业投资活动。 其中,公司为一般有限合伙人,认缴出资人民币 3,000.00 ...
健麾信息收盘下跌1.00%,滚动市盈率100.77倍,总市值30.94亿元
Sou Hu Cai Jing· 2025-07-18 13:25
Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Jianhui Information, which operates in the medical services sector, showing a high PE ratio compared to industry averages [1][2] - As of July 18, Jianhui Information's closing stock price was 22.75 yuan, with a PE ratio of 100.77, significantly higher than the industry average of 44.90 [1][2] - The company's total market capitalization is 3.094 billion yuan, ranking it 39th in the medical services industry based on PE ratio [1][2] Group 2 - Jianhui Information reported a revenue of 77.0622 million yuan for Q1 2025, reflecting a year-on-year increase of 116.27%, while net profit was 3.4261 million yuan, down 34.65% year-on-year [1] - The company's gross profit margin stands at 37.17%, indicating its profitability in the current market environment [1] - As of March 31, 2025, Jianhui Information had 16,423 shareholders, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]
健麾信息(605186) - 2025 Q2 - 季度业绩预告
2025-07-14 08:30
[Summary of Performance Forecast](index=1&type=section&id=Key%20Highlights) The company projects a substantial decline in H1 2025 net profit attributable to shareholders and non-recurring net profit, with decreases exceeding 50% | Indicator | H1 2025 Forecast | H1 2024 Actual | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 5 million - 8 million yuan | 29.54 million yuan | ↓ 72.92% to 83.08% | | Non-recurring Net Profit Attributable to Shareholders | 4.8 million - 7.8 million yuan | 22.36 million yuan | ↓ 65.11% to 78.53% | [Details of Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast) This forecast covers H1 2025, with preliminary estimates projecting unaudited net profit attributable to shareholders between 5 million and 8 million yuan, and non-recurring net profit between 4.8 million and 7.8 million yuan | Project | H1 2025 Estimated Amount | Decrease Compared to Prior Year | Year-on-Year Decrease | | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 5.00 million - 8.00 million yuan | 21.54 million - 24.54 million yuan | 72.92% - 83.08% | | Non-recurring Net Profit Attributable to Shareholders | 4.80 million - 7.80 million yuan | 14.56 million - 17.56 million yuan | 65.11% - 78.53% | - This performance forecast is based on the company's preliminary calculations and has not yet been audited by a certified public accountant[6](index=6&type=chunk) [Review of Prior Period Performance](index=2&type=section&id=II.%20Operating%20Performance%20and%20Financial%20Status%20in%20Prior%20Period) The company disclosed key H1 2024 financial data for comparison, including net profit attributable to shareholders of 29.54 million yuan and non-recurring net profit of 22.36 million yuan | Indicator (Jan-Jun 2024) | Amount | | :--- | :--- | | Total Profit | 34.56 million yuan | | Net Profit Attributable to Shareholders | 29.54 million yuan | | Non-recurring Net Profit Attributable to Shareholders | 22.36 million yuan | | Earnings Per Share | 0.22 yuan | [Analysis of Performance Changes](index=2&type=section&id=III.%20Main%20Reasons%20for%20Performance%20Changes%20in%20Current%20Period) Despite stable revenue growth (approximately 150 million to 160 million yuan) driven by core business recovery and overseas expansion, net profit significantly declined due to lower margins from new businesses and increased R&D investments - During the reporting period, the company's operating revenue maintained stable growth, estimated at approximately **150 million to 160 million yuan**, primarily due to the recovery of core businesses and expansion into overseas markets (Saudi Arabia, Russia, Hong Kong, Taiwan, etc.)[9](index=9&type=chunk) - One primary reason for the profit decline is that emerging business segments, such as intelligent sterile compounding centers and logistics and mobile robots, are still in their incubation period, exhibiting lower profit margins compared to traditional businesses[9](index=9&type=chunk) - The company continues to increase R&D investment, focusing on new product development and technological upgrades like non-whole box packaging and 24-hour unmanned retail, which also impacted current period profit[9](index=9&type=chunk) - The company anticipates future profitability improvements with business structure optimization and enhanced operational efficiency[9](index=9&type=chunk) [Risk Warning and Other Matters](index=2&type=section&id=IV.%20Risk%20Warning) The company emphasizes this performance forecast is a preliminary, unaudited financial estimate, advising investors that final accurate data will be based on the officially disclosed 2025 semi-annual report - This performance forecast represents preliminary calculations by the company's finance department based on professional judgment and has not been audited by a certified public accountant[10](index=10&type=chunk) - The company reminds investors that specific and accurate financial data will be subject to the officially disclosed 2025 semi-annual report, urging caution regarding investment risks[12](index=12&type=chunk)
健麾信息: 上海健麾信息技术股份有限公司关于新增2025年年度日常关联交易预计额度的公告
Zheng Quan Zhi Xing· 2025-06-25 19:45
Core Viewpoint - The company plans to increase its estimated daily related party transaction limit for the year 2025 to a maximum of RMB 24 million, which is deemed necessary for its business development and will not harm the interests of the company or its minority shareholders [1][8]. Summary by Sections Daily Related Party Transactions Overview - The board of directors has approved the proposal for the new estimated limit of daily related party transactions, which will not require shareholder meeting approval [1][2]. - The independent directors have reviewed the proposal and confirmed that it aligns with the company's operational needs and does not harm the interests of other shareholders [1][2]. Previous Related Party Transactions - As of May 31, 2025, the company had executed related party transactions amounting to RMB 5.0347 million against an estimated limit of RMB 22 million for the year [3][4]. New Estimated Daily Related Party Transaction Limit - The new estimated limit for related party transactions with 博科国信 (Wuhan) Technology Co., Ltd. is set at RMB 24 million, which includes procurement and sales activities [1][5]. - The company emphasizes that the transaction amounts are relatively low compared to its total procurement and sales, ensuring that its independence is maintained [1][8]. Related Party Information - 博科国信 is identified as a related party due to shared board members and ownership interests, with the company holding a 4% stake [7][8]. - The company has confirmed that the related party transactions are conducted on fair and market-based terms, ensuring no adverse impact on the company's financial health or operational independence [8]. Purpose and Impact of Related Party Transactions - The transactions are necessary for the company's normal operations and are expected to contribute positively to its performance without creating dependency on the related party [8].
健麾信息: 上海健麾信息技术股份有限公司2024年年度股东大会决议公告
Zheng Quan Zhi Xing· 2025-06-25 19:32
Meeting Details - The shareholders' meeting was held on June 25, 2025, at the conference room of Building A, No. 518, Zhongchen Road, Songjiang District, Shanghai [1] - The total number of shares represented at the meeting was 50.5199% of the total shares [1] Voting Results - All non-cumulative voting proposals were approved with a high percentage of agreement, including: - Proposal 1: 68,599,322 votes in favor (99.8431%) [1] - Proposal 2: 68,598,422 votes in favor (99.8417%) [2] - Proposal 3: 68,597,422 votes in favor (99.8403%) [1] - Proposal 4: 68,603,022 votes in favor (99.8484%) [1] Shareholder Participation - The voting results showed a consistent majority support from A-shareholders, with percentages of approval ranging from 99.8399% to 99.8484% across various proposals [2][1] Legal Compliance - The meeting was conducted in accordance with legal regulations and the company's articles of association, ensuring the validity of the proceedings and voting results [3]
健麾信息: 君合律师事务所上海分所关于上海健麾信息技术股份有限公司2024年年度股东大会的法律意见书
Zheng Quan Zhi Xing· 2025-06-25 19:10
Group 1 - The core opinion of the legal opinion letter is that the procedures for convening and holding the 2024 annual general meeting of shareholders comply with relevant laws, regulations, and the company's articles of association [3][4][5] - The company has provided a notice of the shareholders' meeting, which includes details such as the meeting method, time, location, agenda items, and record date, in accordance with legal requirements [3][4] - The attendance of shareholders and their representatives at the meeting was confirmed, with a total of 68,348,222 shares represented, accounting for 50.2560% of the total voting shares [4][5] Group 2 - The voting process for the shareholders' meeting combined both on-site and online voting methods, and the results were counted and monitored according to the established rules [5][6] - The resolutions presented at the meeting were approved by a majority of the voting shares, indicating that the voting procedures and results were valid and lawful [5][6] - The legal opinion letter will be announced alongside the company's resolutions from the shareholders' meeting, confirming its validity [6]
健麾信息: 第三届监事会第七次会议决议公告
Zheng Quan Zhi Xing· 2025-06-25 18:49
Group 1 - The third meeting of the supervisory board of Shanghai Jianhui Information Technology Co., Ltd. was held on June 25, 2025, with all three supervisors present [1][2] - The supervisory board approved a daily related transaction limit of up to RMB 24 million for the year 2025 with the related party Boke Guoxin (Wuhan) Technology Co., Ltd., which is considered normal business activity [1][2] - The pricing policy for the transactions is deemed fair and reasonable, aligning with the company's operational needs and not harming the interests of shareholders [1][2] Group 2 - The voting results for the meeting were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] - Further details regarding the announcement of the expected daily related transaction limit for 2025 can be found on the Shanghai Stock Exchange website [2]
健麾信息: 上海健麾信息技术股份有限公司关于聘任证券事务代表的公告
Zheng Quan Zhi Xing· 2025-06-25 18:49
Core Points - The company has appointed Ms. Gong Jialin as the securities affairs representative to assist the board secretary in daily operations [1] - Ms. Gong holds a qualification certificate from the Shanghai Stock Exchange and possesses the necessary professional knowledge and capabilities for the role [1][2] - The appointment is effective from the date of the board's approval until the end of the third board's term [1] Company Information - Ms. Gong Jialin was born in February 1996, is a Chinese national, and holds a master's degree [2] - As of the announcement date, Ms. Gong does not hold any shares in the company and has no relationships with major shareholders or company executives [2] - She has not faced any penalties from the China Securities Regulatory Commission or other relevant authorities and is not listed as a dishonest executor [2]